SCHEMBL14213715

SCHEMBL14213715

C/C(=N\Nc1cccc(Br)c1)c1ccc(N=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.51
MEN1 O00255 6/20 0.51
KMT2A Q03164 6/20 0.51
RAB9A P51151 6/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
NPC1 O15118 5/20 0.51
GAA P10253 7/20 0.49
ALDH1A1 P00352 5/20 0.49
HPGD P15428 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C19 P33261 1/20 0.49
MTOR P42345 3/20 0.47
GFER P55789 2/20 0.46
TDP1 Q9NUW8 3/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
CASP6 P55212 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4877431 0.80 MAPT (0.69) MAPTMEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL4877424 0.80 MAPT (0.69) MAPTMEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL20549105 0.75 RAB9A (0.68) MAPTMEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL6285948 0.72 RAB9A (0.66) MAPTMEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL6285944 0.72 RAB9A (0.66) MAPTMEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL11066176 0.72 ALDH1A1 (0.63) MAPTMEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL23539268 0.72 GAA (0.47) MAPTMEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL16115787 0.72 GAA (0.47) MAPTMEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL16115788 0.72 GAA (0.47) MAPTMEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL359987 0.71 SMN1; SMN2 (0.53) MAPTMEN1KMT2ARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7375118-B2 Phenyl-indole compounds for modulating IgE and Inhibiting cellular proliferation AVANIR PHARMACEUTICALS (US) 2008-05-20 US disclosed